Aardvark Therapeutics is voluntarily pausing a global clinical trial testing whether its ARD-101 treatment candidate is superior to a placebo at easing hyperphagia, or insatiable hunger, in people with Prader-Willi syndrome (PWS). The company’s decision to pause the Phase 3 HERO trial (NCT06828861) was based on concerning…
Starting growth hormone therapy before 2 years of age does not increase the risk of sleep apnea or breathing disruptions for children with Prader-Willi syndrome (PWS), according to a new study. The findings offer some reassurance for the current medical trend…
Discussion
Note: This column describes the author’s own thoughts about Vykat XR (diazoxide choline). Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. Anyone who has enjoyed a meal with someone with Prader-Willi syndrome (PWS) has likely noticed their obsession with…
Prader-Will syndrome is a rare and complex genetic condition that results in a variety of physical and mental symptoms. Learn more about the disease here.
Prader-Willi is caused by genetic changes in a particular area of chromosome 15. Learn more about what causes the disease here.
Symptoms of Prader-Willi range from physical impairments to cognitive and behavioral issues. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
